Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
We are a specialty pharmaceutical company that is exploiting our licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics. Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and efficient approval of new formulations of previously approved therapeutics which incorporate our licensed drug delivery technologies. Because the 505(b)(2) approval process is designed to address new formulations of previously approved drugs, we believe it has the potential to be more cost efficient and less time consuming than other FDA approval ( www.biodeliverysciences.com )
BioDelivery Sciences International , Inc.
2501 Aerial Center Parkway Suite 205
Morrisville, North Carolina 27560
USA
Tel: (919) 653-5160
Fax: (919) 653-5161